Search
Now showing items 1-6 of 6
Preprint
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
| Date Issued:
2021 | Copyright:
open access
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Date Issued:
2022 | Copyright:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Date Issued:
2021 | Copyright:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Date Issued:
2020 | Copyright:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Date Issued:
2020 | Copyright:
open access
Preprint
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
| Date Issued:
2021 | Copyright:
open access